Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Success! The link has been copied to your clipboard.
Fresenius Medical Care North America is collaborating with Humana Inc. in a new program designed to improve care and health outcomes for Humana’s members with end-stage renal disease.
Under the program, FMCNA, operating through its Fresenius Health Partners business, will implement its care coordination model to help patients obtain the health care services they need to address their illness and improve their quality of life.
Each patient will be supported by a collaborative team of local nephrologists and clinicians working in partnership with the Care Navigation Unit (CNU), FMCNA’s group of specialized nurses and service coordinators who provide 24/7 support and care coordination services. According to FMCNA, the CNU foresees issues before they arise and helps patients, their families and their providers respond as they happen.
Read the full story at Nephrology News.